Related Experiment Video
Updated: May 23, 2026
04:40
Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Venous thromboembolism and cancer
Donald G MacLellan1, Arthur Richardson, Marcus A Stoodley
1Health Service Performance Improvement Branch, NSW Ministry of Health, North Sydney, New South Wales, Australia. donald.maclellan@doh.health.nsw.gov.au
ANZ Journal of Surgery
|April 18, 2012
Summary
Venous thromboembolism (VTE) is a significant risk for cancer patients. Implementing evidence-based prophylaxis guidelines can reduce VTE-related mortality and morbidity in this vulnerable population.
Area of Science:
- Oncology
- Hematology
- Clinical Medicine
Background:
- Venous thromboembolism (VTE) is a major cause of mortality and morbidity in hospitalized patients.
- Cancer patients face a significantly higher risk (4-6 times) of VTE compared to non-cancer patients.
Purpose of the Study:
- To review current literature on VTE prophylaxis and management in cancer patients.
- To emphasize the importance of evidence-based strategies for VTE prevention in oncology.
Main Methods:
- A comprehensive review of existing literature on VTE prophylaxis and management in cancer patients was conducted.
Main Results:
- Primary VTE prophylaxis is a highly effective strategy for improving patient safety.
- Despite established guidelines and proven benefits, many high-risk cancer patients do not receive adequate VTE prophylaxis.
- There is a gap between recommended best practices and actual clinical implementation for VTE prophylaxis and management.
Conclusions:
- VTE prevention in cancer patients demonstrably reduces morbidity and mortality.
- This review aims to encourage the adoption of best-practice, evidence-based thromboprophylactic management for cancer patients.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...